Extrapleural Pneumonectomy Is Not a Best Option for Mesothelioma Treatment, Says Medical Officials

MesotheliomaMesothelioma is a rare form of cancer, characterized through a long latency period and a short, painful life expectancy following diagnosis, which affects lining of abdominal cavities, most often lung lining and caused by toxic chemical asbestos. Additionally, the diagnosis as well as treatment of asbestos-related diseases such as asbestosis, lung cancer, mesothelioma and other asbestos cancers is complicated.

The lethal disease affects around twenty thousand people worldwide each year and three thousand particularly in America. Earlier, extrapleural pneumonectomy (EPP) has been a common option in mesothelioma treatment, besides its 60% complication rate. The procedure was directed to remove the malignant mesothelioma tumors from patients as well as most affected lung, all affected lymph nodes and surrounding tissue, parts of the heart lining and diaphragm.

However, the UK medical practices terminated the use of EPP in part years. During the symposium of UK and US mesothelioma, many case surgeries were analyzed where the medical officials also backed that EPP is not a best option for mesothelioma treatment.

“The information presented at this Symposium makes an incredibly strong statement that surgical removal of the lung for treatment of malignant pleural mesothelioma should no longer be performed anywhere in the world, just like it has been abandoned already in the U. K”, added the Director of UCLA Mesothelioma Research Program and symposium Chairman, Dr. Robert B. Cameron.